FDA approves additional COVID-19 booster shots for high-risk groups.
TL;DR
The original COVID-19 vaccines from Pfizer and Moderna are no longer authorized in the US as the federal government moves toward updated, simpler vaccine guidance. Anyone who hasn’t received a bivalent COVID-19 booster or any coronavirus vaccination at all is now eligible to receive one dose of the updated shot. The FDA is sticking with a one-shot vaccine schedule for people going forward, except for some exceptions for at-risk groups. An updated version of the COVID-19 vaccine matching the more recent circulating strains is expected in the fall.
- Original COVID-19 shots no longer authorized The Hill
- Second bivalent COVID-19 booster shot available for seniors KOIN 6
- F.D.A. Authorizes Another Covid Booster Shot for People Over 65 The New York Times
- Officials Advise Vulnerable Populations To Get New Booster Vaccine West Virginia Public Broadcasting
- FDA authorizes another COVID booster for some high-risk Americans The Philadelphia Inquirer
Want the full story? Read the original reporting
Read on The Hill